dasabuvir
Showing 1 - 25 of 88
Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)
Completed
- Hepatitis C Infection
- Hepatitis C Virus
- ombitasvir/paritaprevir/ritonavir
- dasabuvir
- (no location specified)
Jul 28, 2021
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- Ombitasvir/Paritaprevir/Ritonavir
- Dasabuvir
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial in Worldwide (Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin)
Completed
- Chronic Hepatitis C Infection
-
San Francisco, California
- +20 more
Sep 7, 2021
Hepatitis C, Acute Trial in Australia, New Zealand, United Kingdom (Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin)
Recruiting
- Hepatitis C, Acute
-
Sydney, New South Wales, Australia
- +10 more
Jun 23, 2021
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
Hepatitis C, Chronic Trial in United States (ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r,
Completed
- Hepatitis C, Chronic
- ombitasvir, paritaprevir/r, dasabuvir + ribavirin
- ombitasvir, paritaprevir/r, dasabuvir
-
Irvine, California
- +3 more
Jan 21, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir
Completed
- Chronic Hepatitis C Infection
- +2 more
- Ledipasvir/Sofosbuvir
- +4 more
-
Hong Kong, Hong Kong, ChinaHumanity and Health GI and Liver Centre
Aug 27, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021
Against HCV Based on Direct-acting Antivirals in Real-life
Completed
- Chronic Hepatitis C Infection
- Telaprevir
- +10 more
-
Seville, Andalusia, SpainValme University Hospital
Jun 22, 2022
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)
HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin
Terminated
- HIV Infections
- Hepatitis C
- Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
- +2 more
-
Birmingham, Alabama
- +15 more
Nov 2, 2021
Hepatitis C Virus (HCV) Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, ribavirin)
Completed
- Hepatitis C Virus (HCV)
- ombitasvir/paritaprevir/ritonavir and dasabuvir
- ribavirin
- (no location specified)
Nov 27, 2019
Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with
Completed
- Chronic Hepatitis C
- SOF/LDV (sofosbuvir/ledipasvir)
- +3 more
-
Little Rock, Arkansas
- +37 more
Dec 1, 2021
Naïve Hepatitis C Virus Genotype 1 Suffering From Fatigue and
Completed
- Chronic Hepatitis C Virus (HCV)
-
St. Gallen, Sankt Gallen, Switzerland
- +4 more
Sep 30, 2019
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Hepatitis C Trial in Ottawa (ABT450r-ABT267-ABT333 +/- Ribavirin)
Completed
- Hepatitis C
- ABT450r-ABT267-ABT333 +/- Ribavirin
-
Ottawa, Ontario, CanadaThe Ottawa Hospital, General Campus
Aug 9, 2019
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and
Completed
- Chronic Hepatitis C
-
Be'er Sheva, HaDarom, Israel
- +17 more
Sep 18, 2019